Cambridge Cognition Plc (AIM: COG) is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. Our software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries. Our digital health products have been used for over 30 years in thousands of academic and industry clinical trials by the world's leading pharmaceutical and biotech companies, academic institutions and health organisations.